Back
Blueprint Medicines Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
BPMC
Blueprint Medicines
Last Price:
$101.69
Seasonality Move:
10.71%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 99.27 | Buy |
| 20-day SMA: | 94.63 | Buy |
| 50-day SMA: | 89.99 | Buy |
| 200-day SMA: | 93.55 | Buy |
| 8-day EMA: | 99.13 | Buy |
| 20-day EMA: | 95.67 | Buy |
| 50-day EMA: | 92.99 | Buy |
| 200-day EMA: | 93.03 | Buy |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.41 | Buy |
| Relative Strength Index (14 RSI): | 63.57 | Buy |
| Chaikin Money Flow: | 378098 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (84.34 - 100) | Buy |
| Bollinger Bands (100): | (84.98 - 104.06) | Buy |
Blueprint Medicines Technical Analysis
| May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 101.69 while BPMC 8-day simple moving average is 99.27, which is a Buy signal.
-
The stock price of BPMC is 101.69 while Blueprint Medicines 20-day SMA is 94.63, which makes it a Buy.
-
Blueprint Medicines 50-day simple moving average is 89.99 while BPMC share price is 101.69, making it a Buy technically.
-
BPMC stock price is 101.69 and Blueprint Medicines 200-day simple moving average is 93.55, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a SellThe current Blueprint Medicines [BPMC] share price is $101.69. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Blueprint Medicines Stock Info
Market Cap:
6.6B
Price in USD:
101.69
Share Volume:
581.7K
Blueprint Medicines 52-Week Range
52-Week High:
121.90
52-Week Low:
73.04
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?The Blueprint Medicines stock price is 101.69 USD today.
-
Will BPMC stock go up or go down?Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators
-
Is Blueprint Medicines overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is overvalued.
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 101.69 while BPMC 8-day exponential moving average is 99.13, which is a Buy signal.
-
The stock price of BPMC is 101.69 while Blueprint Medicines 20-day EMA is 95.67, which makes it a Buy.
-
Blueprint Medicines 50-day exponential moving average is 92.99 while BPMC share price is 101.69, making it a Buy technically.
-
BPMC stock price is 101.69 and Blueprint Medicines 200-day simple moving average is 93.03, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.46 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
-
BPMC Moving Average Covergence Divergence (MACD) indicator is 3.41, suggesting Blueprint Medicines is a Buy
-
Blueprint Medicines Relative Strength Index (RSI) is 63.57, which suggest Blueprint Medicines is overbought
-
The Bollinger Bands (25) for Blueprint Medicines is (84.34 - 100), which suggest Blueprint Medicines is a Buy
-
The Bollinger Bands (100) for Blueprint Medicines is (84.98 - 104.06), which suggest Blueprint Medicines is a Buy
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.